Home  |  Contact

UniProtKB/Swiss-Prot P51460: Variant p.Val43Leu

Insulin-like 3
Gene: INSL3
Variant information

Variant position:  43
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Type of variant:  Polymorphism
The variants are classified into three categories: Disease, Polymorphism and Unclassified.
  • Disease: Variants implicated in disease according to literature reports.
  • Polymorphism: Variants not reported to be implicated in disease.
  • Unclassified: Variants with uncertain implication in disease according to literature reports. Evidence against or in favor of a pathogenic role is limited and/or conflicting.

Residue change:  From Valine (V) to Leucine (L) at position 43 (V43L, p.Val43Leu).
Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.

Physico-chemical properties:  Similar physico-chemical property. Both residues are medium size and hydrophobic.
The physico-chemical property of the reference and variant residues and the change implicated.

BLOSUM score:  1
The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page



Sequence information

Variant position:  43
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Protein sequence length:  131
The length of the canonical sequence.

Location on the sequence:   PAPTPEMREKLCGHHFVRAL  V RVCGGPRWSTEARRPATGGD
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.

Residue conservation: 
The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         PAPTPEMREKLCGHHFVRALVRVC--GGPRWSTE-ARRPATGGD

                              SAPAPGAREKLCGHHFVRALVRVC--GGPRWSSE-DGRRVA

Chimpanzee                    PAPTPEMREKLCGHHFVRALVRVC--GGPRWSTE-ARRPAA

Mouse                         PQP-PEARAKLCGHHLVRTLVRVC--GGPRWSPE-ATQPVE

Rat                           PQP-PEARAKLCGHHLVRALVRVC--GGPRWSPE-ATQPVD

Pig                           PAPAQEAPEKLCGHHFVRALVRLC--GGPRWSPE-DGRAVA

Bovine                        PAAAQEAPEKLCGHHFVRALVRLC--GGPRWSSEEDGRPVA

Drosophila                    GV---QATMKLCGRKLPETLSKLCVYG---FNAM-TKRTLD

Sequence annotation in neighborhood:  
The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.

TypePositionsDescription
Peptide 21 – 55 Insulin-like 3 B chain
Disulfide bond 34 – 116 Interchain (between B and A chains)
Helix 36 – 46


Literature citations

Genetic analysis of the INSL3 gene in patients with maldescent of the testis.
Lim H.N.; Raipert-de Meyts E.; Skakkebaek N.E.; Hawkins J.R.; Hughes I.A.;
Eur. J. Endocrinol. 144:129-137(2001)
Cited for: VARIANTS GLY-24; LEU-43; SER-49; ALA-60 AND HIS-102;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.